Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression

• Tipo: Artigo em Revista Científica Internacional
• Data: 2017

Autores

Baglio, SR (Autor) Outra; Lagerweij, T (Autor) Outra; Perez Lanzon, M (Autor) Outra; Ho, XD (Autor) Outra; Leveille, N (Autor) Outra; Melo, SA (Autor) FMUP; Cleton Jansen, AM (Autor) Outra; Jordanova, ES (Autor) Outra; Roncuzzi, L (Autor) Outra; Greco, M (Autor) Outra; van Eijndhoven, MAJ (Autor) Outra; Grisendi, G (Autor) Outra; Dominici, M (Autor) Outra; Bonafede, R (Autor) Outra; Lougheed, SM (Autor) Outra; de Gruijl, TD (Autor) Outra; Zini, N (Autor) Outra; Cervo, S (Autor) Outra; Steffan, A (Autor) Outra; Canzonieri, V (Autor) Outra; Martson, A (Autor) Outra; Maasalu, K (Autor) Outra; Koks, S (Autor) Outra; Wurdinger, T (Autor) Outra; Baldini, N (Autor) Outra; Pegtel, DM (Autor) Outra

Revista

Título: Clinical Cancer Research

Vol. 23

Páginas: 3721-3733

ISSN: 1078-0432

Editora: American Association for Cancer Research

Indexação

ISI Web of Knowledge - 103 Citações

Scopus - 100 Citações

Outras Informações

ID Authenticus: P-00R-APV

DOI: 10.1158/1078-0432.ccr-16-2726

Abstract (EN): Purpose: Human osteosarcoma is a genetically heterogeneous bone malignancy with poor prognosis despite the employment of aggressive chemotherapy regimens. Because druggable driver mutations have not been established, dissecting the interactions between osteosarcoma cells and supporting stroma may provide insights into novel therapeutic targets. Experimental Design: By using a bioluminescent orthotopic xenograft mouse model of osteosarcoma, we evaluated the effect of tumor extracellular vesicle (EV)-educated mesenchymal stem cells (TEMSC) on osteosarcoma progression. Characterization and functional studies were designed to assess the mechanisms underlying MSC education. Independent series of tissue specimens were analyzed to corroborate the preclinical findings, and the composition of patient serum EVs was analyzed after isolation with size-exclusion chromatography. Results: We show that EVs secreted by highly malignant osteosarcoma cells selectively incorporate a membrane-associated form of TGF beta, which induces proinflammatory IL6 production by MSCs. TEMSCs promote tumor growth, accompanied with intratumor STAT3 activation and lung metastasis formation, which was not observed with control MSCs. Importantly, intravenous administration of the anti-IL6 receptor antibody tocilizumab abrogated the tumor-promoting effects of TEMSCs. RNA-seq analysis of human osteosarcoma tissues revealed a distinct TGF beta-induced prometastatic gene signature. Tissue microarray immunostaining indicated active STAT3 signaling in human osteosarcoma, consistent with the observations in TEMSC-treated mice. Finally, we isolated pure populations of EVs from serum and demonstrated that circulating levels of EV-associated TGF beta are increased in osteosarcoma patients. Conclusions: Collectively, our findings suggest that TEMSCs promote osteosarcoma progression and provide the basis for testing IL6- and TGF beta-blocking agents as new therapeutic options for osteosarcoma patients. (C) 2017 AACR.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 13